Inter-molecular β-sheet structure facilitates lung-targeting siRNA delivery
Size-dependent passive targeting based on the characteristics of tissues is a basic mechanism of drug delivery. While the nanometer-sized particles are efficiently captured by the liver and spleen, the micron-sized particles are most likely entrapped within the lung owing to its unique capillary structure and physiological features. To exploit this property in lung-targeting siRNA delivery, we designed and studied a multi-domain peptide named K-β, which was able to form inter-molecular β-sheet structures. Results showed that K-β peptides and siRNAs formed stable complex particles of 60 nm when mixed together. A critical property of such particles was that, after being intravenously injected into mice, they further associated into loose and micron-sized aggregates, and thus effectively entrapped within the capillaries of the lung, leading to a passive accumulation and gene-silencing. The large size aggregates can dissociate or break down by the shear stress generated by blood flow, alleviating the pulmonary embolism. Besides the lung, siRNA enrichment and targeted gene silencing were also observed in the liver. This drug delivery strategy, together with the low toxicity, biodegradability, and programmability of peptide carriers, show great potentials in vivo applications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
---|---|
Enthalten in: |
Scientific reports - 6(2016) vom: 09. März, Seite 22731 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Jihan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biological Products |
---|
Anmerkungen: |
Date Completed 03.01.2017 Date Revised 24.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/srep22731 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM258224096 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM258224096 | ||
003 | DE-627 | ||
005 | 20240324233253.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/srep22731 |2 doi | |
028 | 5 | 2 | |a pubmed24n1344.xml |
035 | |a (DE-627)NLM258224096 | ||
035 | |a (NLM)26955887 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Jihan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Inter-molecular β-sheet structure facilitates lung-targeting siRNA delivery |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.01.2017 | ||
500 | |a Date Revised 24.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Size-dependent passive targeting based on the characteristics of tissues is a basic mechanism of drug delivery. While the nanometer-sized particles are efficiently captured by the liver and spleen, the micron-sized particles are most likely entrapped within the lung owing to its unique capillary structure and physiological features. To exploit this property in lung-targeting siRNA delivery, we designed and studied a multi-domain peptide named K-β, which was able to form inter-molecular β-sheet structures. Results showed that K-β peptides and siRNAs formed stable complex particles of 60 nm when mixed together. A critical property of such particles was that, after being intravenously injected into mice, they further associated into loose and micron-sized aggregates, and thus effectively entrapped within the capillaries of the lung, leading to a passive accumulation and gene-silencing. The large size aggregates can dissociate or break down by the shear stress generated by blood flow, alleviating the pulmonary embolism. Besides the lung, siRNA enrichment and targeted gene silencing were also observed in the liver. This drug delivery strategy, together with the low toxicity, biodegradability, and programmability of peptide carriers, show great potentials in vivo applications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Biological Products |2 NLM | |
650 | 7 | |a Carrier Proteins |2 NLM | |
650 | 7 | |a Drug Carriers |2 NLM | |
650 | 7 | |a RNA, Small Interfering |2 NLM | |
700 | 1 | |a Li, Dong |e verfasserin |4 aut | |
700 | 1 | |a Wen, Hao |e verfasserin |4 aut | |
700 | 1 | |a Zheng, Shuquan |e verfasserin |4 aut | |
700 | 1 | |a Su, Cuicui |e verfasserin |4 aut | |
700 | 1 | |a Yi, Fan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jue |e verfasserin |4 aut | |
700 | 1 | |a Liang, Zicai |e verfasserin |4 aut | |
700 | 1 | |a Tang, Tao |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Demin |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Li-He |e verfasserin |4 aut | |
700 | 1 | |a Liang, Dehai |e verfasserin |4 aut | |
700 | 1 | |a Du, Quan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 6(2016) vom: 09. März, Seite 22731 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:6 |g year:2016 |g day:09 |g month:03 |g pages:22731 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/srep22731 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 6 |j 2016 |b 09 |c 03 |h 22731 |